Toivonen Päivi, Kivelä Tero
Ocular Oncology Service, Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland.
Ophthalmology. 2006 May;113(5):865-73. doi: 10.1016/j.ophtha.2005.10.059. Epub 2006 Mar 13.
To describe the characteristics and evolution of pigmented episcleral deposits after brachytherapy for uveal melanoma to determine their origin and association with melanoma-related mortality.
Noncomparative case series.
Two hundred eleven patients (108 males, 103 females; median age, 61 years; range, 14-88 years) who were treated with a single ruthenium and iodine plaque therapy (median dose to tumor base, 475 Gy and 392 Gy, respectively) for a choroidal and ciliary body melanoma. Median tumor diameter and height were 12 mm and 5.5 mm, respectively. Eighty-eight patients were treated prospectively during the study.
The number and location of pigmented episcleral deposits were recorded under the slit lamp during each visit after brachytherapy. The association of the deposits with tumor characteristics and survival was analyzed with logistic regression and Kaplan-Meier analysis, respectively.
Number and location of episcleral deposits, melanoma-related mortality.
The pigmented episcleral deposits ranged from black and brownish spots to slightly thickened patches. Most deposits appeared within the first 6 months after brachytherapy. By 1 year, 85% (95% confidence interval, 77-93) of eyes had at least 1 deposit (median, 6). The deposits increased in number until 7 years from irradiation, and decreased with increasing distance from tumor center. An association between the number of deposits at 1 and 2 years and subsequent melanoma-related mortality could not be confirmed (P = 0.80 and P = 0.31, respectively).
Pigmented macrophage-related episcleral deposits are found in most eyes with uveal melanoma after brachytherapy. Their association with plaque size and isotope rather than with tumor size suggests that radiation atrophy of retinal pigment epithelium and choroid in addition to tumor regression contributes to the formation of the deposits. Knowledge of their existence may save patients from unnecessary enucleation.
描述葡萄膜黑色素瘤近距离放射治疗后巩膜色素沉着沉积物的特征及演变,以确定其起源及与黑色素瘤相关死亡率的关联。
非对照病例系列。
211例患者(男性108例,女性103例;中位年龄61岁;范围14 - 88岁),接受单次钌和碘敷贴治疗(肿瘤基底中位剂量分别为475 Gy和392 Gy),治疗脉络膜和睫状体黑色素瘤。肿瘤中位直径和高度分别为12 mm和5.5 mm。88例患者在研究期间接受前瞻性治疗。
在近距离放射治疗后的每次随访中,于裂隙灯下记录巩膜色素沉着沉积物的数量和位置。分别采用逻辑回归和Kaplan-Meier分析沉积物与肿瘤特征及生存的关联。
巩膜沉积物的数量和位置、黑色素瘤相关死亡率。
巩膜色素沉着沉积物从黑色和褐色斑点到略增厚的斑块不等。大多数沉积物在近距离放射治疗后的前6个月内出现。到1年时,85%(95%置信区间,77 - 93)的眼至少有1个沉积物(中位值为6个)。沉积物数量在照射后7年内增加,且离肿瘤中心越远数量越少。1年和2年时沉积物数量与随后黑色素瘤相关死亡率之间的关联未得到证实(P值分别为0.80和0.31)。
近距离放射治疗后的大多数葡萄膜黑色素瘤患眼中可发现与色素巨噬细胞相关的巩膜沉积物。它们与敷贴大小和同位素而非肿瘤大小相关,这表明除肿瘤消退外,视网膜色素上皮和脉络膜的放射性萎缩也有助于沉积物的形成。了解它们的存在可避免患者不必要的眼球摘除。